| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44c2e1aaf228297cd59cddcd774d2147
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac5d5f82c11f8d94ae98ea9d0b033404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e078efe4739e86ce939ab69a84c1c5b1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-75 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-75 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-75 |
| filingDate |
2019-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12190591fbcbb206446459dcc9872f50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e16e583efee01b34f5d208ae1f4a15d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e3fa5f9c4bc4931f08ab77075594a4c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e472b0683eeb2ecfe142d2e8508df4b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fb2221198875404063540cda25bedca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be8ba4c46d5d7fb247a49ff32e76852e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ad679b80cc7324ae8bb88a3840e8f65 |
| publicationDate |
2021-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-102019020328-A2 |
| titleOfInvention |
hybrid compounds (2-cyano-3- (indole-3-yl) -n-phenylacrylamide with immunomodulatory, anti-inflammatory and analgesic potential |
| abstract |
hybrid compounds (2-cyano-3- (indole-3-yl) -n-phenylacrylamide derived from paracetamol and indomethacin with potential immunomodulatory, anti-inflammatory and analgesic potential.The present invention relates to a composition in the field of medicinal chemistry and these are hybrid compounds (2-cyano-3- (indole-3-yl) -n-phenylacrylamide derived from paracetamol and indomethacin with potential immunomodulatory, anti-inflammatory and analgesic potential. fbdd (fragment besid drug design) by means of an amidation reaction between substituted anilines and ethyl 2-cyanoacetate, followed by a knovenagel condensation reaction with different substituted indole aldehydes. |
| priorityDate |
2019-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |